PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2

PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2

The rapid development of safe and effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) is a necessary response to coronavirus outbreak. Here, we developed PRAK-03202, the world's first triple antigen virus-like particle vaccine candidate, by cloning and transf...

Full description

Bibliographic Details
Main Authors: Saumyabrata Mazumder, Ruchir Rastogi, Avinash Undale, Kajal Arora, Nupur Mehrotra Arora, Biswa Pratim, Dilip Kumar, Abyson Joseph, Bhupesh Mali, Vidya Bhushan Arya, Sriganesh Kalyanaraman, Abhishek Mukherjee, Aditi Gupta, Swaroop Potdar, Sourav Singha Roy, Deepak Parashar, Jeny Paliwal, Sudhir Kumar Singh, Aelia Naqvi, Apoorva Srivastava, Manglesh Kumar Singh, Devanand Kumar, Sarthi Bansal, Satabdi Rautray, Manish Saini, Kshipra Jain, Reeshu Gupta, Prabuddha Kumar Kundu
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:Heliyon
Subjects:
Virus like particle
Vaccine
Humoral immune response
Convalescent COVID-19 patients
Electron microscopy
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844021022271

Internet

http://www.sciencedirect.com/science/article/pii/S2405844021022271

Similar Items